Music platforms remain immune to Covid-19 as investments intensify

Taylor Swift is, in a sense, immune to Covid-19.

Not literally, of course. But as an investment prospect, her work sits alongside assets whose values have stayed strong, but which won’t suffer if we get a working vaccine and consumers’ lives start to return to normal. If you’re in the market for steady returns, regardless of the coronavirus situation, there are worse places to look.

Just last year private equity giant Carlyle Group partnered with Scooter Braun, the manager of artists like Justin Bieber and Ariana Grande, to acquire Big Machine Records, Taylor Swift’s label, for $300 million. That group has now sold Swift’s back catalogue alone for the same amount, while retaining the rest of the label’s inventory.